EMA Recommends New Approaches To Characterize Toxicity Of Anticancer Drugs
Executive Summary
The European Medicines Agency has outlined new approaches for collecting and reporting of safety data to help better understand the toxicity and tolerability profiles of anticancer medicines. The new recommendations are published in an updated guideline that will apply from April 2018.